COVID-19: US Health Secretary Alex Azar says vaccine is not a race, doubts Russia

By: |
August 12, 2020 3:14 PM

Azar's comments during a visit to Taiwan on Wednesday follow Russian President Vladimir Putin's announcement that his country was the first to approve a coronavirus vaccine, prompting doubts about the science and safety behind that purported achievement.

He says four of the six companies under contract have reported testing results showing they produce more antibodies for the virus than people who have survived COVID-19, without severe side effects.He says four of the six companies under contract have reported testing results showing they produce more antibodies for the virus than people who have survived COVID-19, without severe side effects.

US Health Secretary Alex Azar says the push to develop a COVID-19 vaccine is not a race to be first. Azar’s comments during a visit to Taiwan on Wednesday follow Russian President Vladimir Putin’s announcement that his country was the first to approve a coronavirus vaccine, prompting doubts about the science and safety behind that purported achievement.

Azar says the US is combining the powers of its government, economy and biopharmaceutical industry to deliver as quickly as we can for the benefit of the United States’ citizens, but also for the people of the world, safe and effective vaccines”.

He says the US has secured an advanced manufacturing contract for a vaccine being developed by the company Moderna and has supply agreements with five other firms who have vaccines in the works.

He says four of the six companies under contract have reported testing results showing they produce more antibodies for the virus than people who have survived COVID-19, without severe side effects.

Azar says two companies’ vaccine candidates have entered the third phase of trials while the Russian vaccine is just now embarking on that stage with no information having been disclosed.

He says the US process should allow the production of a gold-standard, safe and effective vaccine available in the tens of millions of doses by the end of the year.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Coronavirus in India Live News: Maximum mess, minimum vaccine – No CoWin slots, jab centres shut, states fight over quota
2Covid-19: Vaccine supplies to get a leg-up, says govt
3BIBCOL to manufacture 2 crore doses of Covaxin every month in UP